Does omega-3 fish oil improve memory?
In a trial of 485 healthy people aged 55 and over whose memory had weakened with age, those who took the omega-3 fat DHA as a supplement learned and remembered better than those on a placebo [1]. People who eat more fish or have more DHA in their blood develop dementia less often [2] [3] [4], but in trials that gave omega-3 supplements, dementia was no less common [5]. The largest trials, which took older adults whatever their memory, found no gain in memory or thinking with omega-3 supplements [6] [7] [8], and omega-3 supplements did not slow Alzheimer's disease [9] [10]. For people with mild memory or thinking problems, the evidence is mixed: three trials found better memory or thinking with DHA [11] [12] [13], but three found no gain in memory [14] [15] [16].
What do scientific studies say about omega-3 impact on memory and focus?
| Who took part | What they took, and what happened |
|---|---|
| 485 healthy people aged 55 and over whose memory had weakened with age | 900 mg of the omega-3 fat DHA a day for 6 months. They learned and remembered better than with a placebo, on a pattern-location test and a word test [1]. |
| 65 healthy adults aged 50 to 75 | 2.2 g of omega-3 from fish oil a day for 6 months. Planning and switching between tasks came out better than with a placebo [17]. |
| 4,218 healthy adults aged 60 and over | A 1 g fish oil capsule a day, with 840 mg of omega-3, for 2 to 3 years. Memory and thinking came out the same as with a placebo [6]. |
| 3,501 older adults with the eye disease macular degeneration | 1 g of omega-3 a day for 5 years. Memory and thinking came out the same as with a placebo [7]. |
| 2,157 healthy adults aged 70 and over | 1 g of omega-3 from algae oil a day for 3 years. A test of overall thinking came out the same as with a placebo [8]. |
| 402 people with mild to moderate Alzheimer's disease | 2 g of DHA a day for 18 months. Memory and thinking declined as fast as with a placebo [9]. |
| 36 older people with mild memory or thinking problems | Fish oil rich in DHA for 12 months. Memory, including recall of words, came out better than with a placebo [11]. |
| 240 older people with mild memory or thinking problems | 2 g of DHA a day for 2 years. On an IQ test, overall thinking and repeating numbers came out better than with a placebo [12]. |
| 240 older people with mild memory or thinking problems, in a second trial by the same team | 800 mg of DHA a day for 6 months, alone or with folic acid. On an IQ test, overall thinking came out better than with a placebo, and best with both together [13]. |
| 1,680 people aged 70 and over with memory complaints, slow walking or trouble with a daily task | Every day for 3 years: 800 mg of DHA and 225 mg of EPA, the other omega-3 in fish oil. Memory and thinking came out the same as with a placebo [14]. |
| 76 people with memory or thinking problems or Alzheimer's disease | 1.2 g of EPA and DHA a day for 4 months. Memory, thinking and mood came out the same as with a placebo [15]. |
| 50 older people with mild memory or thinking problems | Fish oil rich in EPA or in DHA for 6 months. Memory came out the same as with a placebo oil that contains omega-6, a different type of fat [16]. |
What is omega-3, and where does it come from?
Omega-3s are fats the body needs but cannot make on its own, so they come from food [10]. Oily fish such as salmon, mackerel, herring and sardines give the two omega-3s in fish oil, EPA and DHA, and DHA is the most common omega-3 in the brain [9] [18] [19].
Flaxseed, chia seeds, walnuts and canola oil give a third omega-3, ALA [19]. The body uses ALA mainly as raw material for EPA and DHA, but it turns only a small part into EPA and hardly any into DHA: eating more ALA raises EPA in the blood, but not DHA [20]. For people who eat no fish, oil from algae is a source of DHA, and some algae oils also contain EPA [19].
Does fish oil help memory in older adults?
A trial of DHA: better learning and memory. 485 healthy people aged 55 and over, whose memory had weakened with age, took 900 mg of the omega-3 fat DHA or a placebo every day for 6 months. In the main test, boxes on a screen opened to show patterns, and people had to point to the box where each pattern had been. With DHA, errors on this test fell almost twice as much as with the placebo, and people recognised more of the words they had seen before. Planning came out the same, and so did working memory, the memory you use to keep a number in mind while you use it [1]. The trial was paid for by Martek, the company that made the DHA [1] [21].
A trial of fish oil: better planning. 65 healthy adults aged 50 to 75 took 2.2 g of omega-3 from fish oil or a placebo every day for 6 months. With fish oil, they did better at planning and at switching between tasks [17].
The largest trials: no gain. Three trials gave a 1 g omega-3 capsule a day or a placebo to between 2,157 and 4,218 older adults. Unlike the DHA trial, they took people whatever their memory, and their capsules held EPA and DHA together [6] [7] [8]. After 2 to 5 years, memory and thinking came out the same in both groups [6] [7] [8].
The reviews disagree. A 2020 review of 25 trials in adults without dementia found a mild gain in memory but none in overall thinking [22]. Another 2020 review combined 38 trials with 49,757 people and found almost no difference in overall thinking: in 13 of them, people on omega-3 did 0.1 points better on a common test of memory and thinking scored from 0 to 30 [5]. A 2025 review of 58 trials found better overall thinking, language, short-term memory and skills for judging shapes and space with omega-3 than without, but no clear gain in attention or speed of thinking. The gain in overall thinking grew with the dose up to 1.5 g a day and was smaller at higher doses. For overall thinking, the authors rated the certainty of the evidence as low. They also found signs that trials without a gain had gone unpublished, which makes the gain across all trials look larger than it is [23].
Does omega-3 lower the risk of dementia?
A review of 21 studies with 181,580 people found that each extra portion of fish a week went with a 5% lower risk of dementia and a 7% lower risk of Alzheimer's disease [2].
Studies that measured the omega-3 fat DHA in blood found the same. In one, 899 older people were followed for 9 years, and the quarter with the most DHA in their blood developed dementia about half as often as the rest [3]. In another, 1,490 people aged 65 and over were followed for 7 years, and the fifth with the most DHA in their red blood cells developed Alzheimer's disease about half as often as the fifth with the least [4]. A study of fish oil itself compared 211,094 people aged 60 and over who did or did not take it. Over about 12 years, those who took fish oil were diagnosed with dementia 9% less often, but not less often with Alzheimer's disease [24].
These studies observed people and gave no one omega-3. People who take fish oil differ in other ways: in the fish oil study, they exercised more, smoked less and had diabetes less often, and the authors wrote that a healthy lifestyle is hard to tell apart from the fish oil [24]. Trials that gave omega-3 and counted new cases found no difference: in 6 trials with 33,496 people, dementia and other illnesses that affect thinking were as common in people given omega-3 as in those given a placebo or less omega-3 [5].
Does omega-3 help people with mild memory problems?
These are people whose memory or thinking problems are greater than usual for their age, but who do not have dementia. Trials in these people disagree.
Three trials found better memory or thinking with the omega-3 fat DHA. In one, 36 older people took fish oil rich in DHA or a placebo for 12 months, and memory came out better with fish oil [11]. The other two come from the same research team, and each had 240 older people. In the first, the group on 2 g of DHA a day did better on an IQ test after 2 years than the placebo group [12]. In the second, the groups on 800 mg of DHA a day, on folic acid, and on both together each did better on an IQ test after 6 months than the placebo group, and the group on both did best [13].
Three trials found no gain in memory. The largest took people aged 70 and over who had told their doctor about memory complaints, walked slowly or had trouble with a daily task. 1,680 of them took a placebo or omega-3 every day for 3 years. The omega-3 was 800 mg of DHA and 225 mg of EPA, the other omega-3 in fish oil. Memory and thinking came out the same in both groups [14]. In another, 76 people took omega-3 or a placebo for 4 months: 57 with memory or thinking problems and 19 with Alzheimer's disease. Memory, thinking and mood came out the same in both groups [15]. In a trial of 50 people over 65, neither fish oil rich in EPA nor fish oil rich in DHA changed memory more than a placebo oil that contains omega-6, a different type of fat, instead of omega-3 [16].
A 2024 review combined 12 trials with 1,124 people with mild memory or thinking problems. Overall thinking came out better with omega-3. Memory came out better only when the authors left out the trial of 76 people, which included people with Alzheimer's disease. Some trials had the same lead researcher, and the authors could not rule out that the same people were counted in more than one trial [25].
Together with B vitamins. In an Oxford trial, people over 70 with mild memory or thinking problems took folic acid, B6 and B12, or a placebo, for 2 years. The vitamins slowed brain shrinkage and memory decline in people who started with high levels of omega-3 in their blood, but made no difference in people with low levels [26] [27]. Our article on vitamin B12 and memory covers this trial.
Can omega-3 slow Alzheimer's disease?
In people who already have Alzheimer's disease, trials of the omega-3 fats DHA and EPA found no slower decline, except in one small group.
An 18-month trial of DHA: no slower decline. 402 people with mild to moderate Alzheimer's disease took 2 g of DHA made from algae or a placebo every day for 18 months. Memory and thinking declined as fast in both groups, and the brain shrank as fast too [9].
A 6-month trial of DHA and EPA: slower decline only in the mildest cases. 204 people with mild to moderate Alzheimer's disease took 1.7 g of DHA and 0.6 g of EPA a day, or a placebo. Memory and thinking declined as fast with omega-3 as with the placebo, except in the 32 people with the mildest symptoms: their score on a common test of memory and thinking, scored from 0 to 30, stopped declining with omega-3, while it declined with the placebo [28] [29]. The researchers picked out this group only after the trial [29].
A 2016 review combined 3 trials with 632 people with mild to moderate Alzheimer's disease. After 6 months, memory, thinking and daily activities came out the same with omega-3 as with a placebo [10].
The Alzheimer's risk gene APOE4. APOE4 is a form of a gene that raises the risk of Alzheimer's disease, and people who carry it handle omega-3 differently [30]. In the 18-month trial, memory and thinking declined more slowly with DHA in people without this gene variant. But this was one of many comparisons, and when many are made, some come out positive by chance. The company that made the DHA filed a patent for DHA in people without APOE4, and the patent names two of the trial's lead researchers [9]. A later trial gave 2 g of DHA a day or a placebo for 2 years to 365 people who had a risk factor for dementia but no dementia, nearly half of them with APOE4. DHA rose in the fluid around the brain, with and without the gene, so it reached the brain. But memory, thinking and brain size came out the same as with the placebo [30].
Is fish oil safe?
Side effects of omega-3 supplements are usually mild: an unpleasant taste, bad breath, bad-smelling sweat, headache, heartburn, nausea and diarrhoea [19]. Cod liver oil contains vitamins A and D as well as omega-3, and both vitamins can be harmful in large amounts [19].
Omega-3 supplements raise the risk of atrial fibrillation, an irregular heartbeat that makes a stroke more likely [31]. A review of 7 large heart trials with 81,210 people found 25% more atrial fibrillation with omega-3 than with a placebo. The risk rose with the dose: 12% more at 1 g a day or less, and 49% more above 1 g [32].
Trials that measured bleeding found no rise in heavy bleeding at up to 5 g a day of EPA and DHA, the two omega-3s in fish oil. Above 5 g, there is too little evidence to tell [33]. But in people who take blood thinners, omega-3 supplements can add to the risk of bleeding [18]. In 2012, the EU's food safety authority (EFSA) found too little data to set an upper limit. It found no safety concerns for adults at up to 5 g of EPA and DHA a day from supplements, or up to 1 g of DHA alone [34]. No upper limit means only that no harm had been shown by 2012. Heart trials published since then found more atrial fibrillation, most of all above 1 g a day [32].
Q&A
How much omega-3 did the memory trials use?
Most of these trials gave between 800 mg and 2.3 g of omega-3 a day. The trial that found better learning and memory in healthy people used 900 mg of the omega-3 fat DHA [1], and the largest trials, which found no gain, used 1 g [6] [7] [8]. For heart health, European adults are advised to get 250 to 500 mg a day of the two omega-3s in fish oil, EPA and DHA [34].
Is DHA or EPA better for memory?
Most trials that found better memory or thinking gave DHA alone or fish oil rich in DHA [1] [11] [12] [13]; the trial that found better planning gave fish oil with more EPA than DHA [17]. Two trials that compared fish oil rich in DHA with fish oil rich in EPA found no gain in memory with either [35] [16].
Does omega-3 help memory and focus in younger adults?
Two trials in healthy young adults disagree. In the first, 176 adults aged 18 to 45 who got little DHA from food took 1.16 g of DHA or a placebo every day for 6 months. With DHA, they answered memory tasks faster, and the women also remembered more [36]. In the second, 159 adults aged 18 to 35 took 1 g a day of fish oil rich in DHA, fish oil rich in EPA, or a placebo for 12 weeks, and memory, attention and mood came out the same. People on fish oil rich in EPA felt less mentally tired during hard tasks, a finding the authors said needs checking [35].
Sources
- Yurko-Mauro K, McCarthy D, Rom D, et al.; MIDAS Investigators. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer’s & Dementia. 2010;6(6):456–464. doi.org/10.1016/j.jalz.2010.01.013
- Zhang Y, Chen J, Qiu J, Li Y, Wang J, Jiao J. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. American Journal of Clinical Nutrition. 2016;103(2):330–340. doi.org/10.3945/ajcn.115.124081
- Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Archives of Neurology. 2006;63(11):1545–1550. doi.org/10.1001/archneur.63.11.1545
- Sala-Vila A, Satizabal CL, Tintle N, et al. Red blood cell DHA is inversely associated with risk of incident Alzheimer’s disease and all-cause dementia: Framingham Offspring Study. Nutrients. 2022;14(12):2408. doi.org/10.3390/nu14122408
- Brainard JS, Jimoh OF, Deane KHO, et al.; PUFAH group. Omega-3, omega-6, and polyunsaturated fat for cognition: systematic review and meta-analysis of randomized trials. Journal of the American Medical Directors Association. 2020;21(10):1439–1450. doi.org/10.1016/j.jamda.2020.02.022
- Kang JH, Vyas CM, Okereke OI, et al. Marine n-3 fatty acids and cognitive change among older adults in the VITAL randomized trial. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2022;8(1):e12288. doi.org/10.1002/trc2.12288
- Chew EY, Clemons TE, Agrón E, et al.; AREDS2 Research Group. Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial. JAMA. 2015;314(8):791–801. doi.org/10.1001/jama.2015.9677
- Bischoff-Ferrari HA, Vellas B, Rizzoli R, et al.; DO-HEALTH Research Group. Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial. JAMA. 2020;324(18):1855–1868. doi.org/10.1001/jama.2020.16909
- Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304(17):1903–1911. doi.org/10.1001/jama.2010.1510
- Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A. Omega-3 fatty acids for the treatment of dementia. Cochrane Database of Systematic Reviews. 2016;(4):CD009002. doi.org/10.1002/14651858.CD009002.pub3
- Lee LK, Shahar S, Chin AV, Yusoff NA. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology. 2013;225(3):605–612. doi.org/10.1007/s00213-012-2848-0
- Zhang YP, Lou Y, Hu J, Miao R, Ma F. DHA supplementation improves cognitive function via enhancing Aβ-mediated autophagy in Chinese elderly with mild cognitive impairment: a randomised placebo-controlled trial. Journal of Neurology, Neurosurgery & Psychiatry. 2018;89(4):382–388. doi.org/10.1136/jnnp-2017-316176
- Li M, Li W, Gao Y, et al. Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial. European Journal of Nutrition. 2021;60(4):1795–1808. doi.org/10.1007/s00394-020-02373-3
- Andrieu S, Guyonnet S, Coley N, et al.; MAPT Study Group. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurology. 2017;16(5):377–389. doi.org/10.1016/S1474-4422(17)30040-6
- Phillips MA, Childs CE, Calder PC, Rogers PJ. No effect of omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impairment and probable Alzheimer’s disease: a randomised controlled trial. International Journal of Molecular Sciences. 2015;16(10):24600–24613. doi.org/10.3390/ijms161024600
- Sinn N, Milte CM, Street SJ, et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. British Journal of Nutrition. 2012;107(11):1682–1693. doi.org/10.1017/S0007114511004788
- Witte AV, Kerti L, Hermannstädter HM, et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cerebral Cortex. 2014;24(11):3059–3068. doi.org/10.1093/cercor/bht163
- Cleveland Clinic. Omega-3 fatty acids. Updated 17 November 2022. my.clevelandclinic.org/health/articles/17290-omega-3-fatty-acids
- US National Center for Complementary and Integrative Health (NCCIH). Omega-3 supplements: what you need to know. Updated November 2024. www.nccih.nih.gov/health/omega3-supplements-what-you-need-to-know
- Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development. 2005;45(5):581–597. doi.org/10.1051/rnd:2005047
- News-Medical. Algal DHA improves memory function in healthy aging adults: MIDAS. 4 May 2010. www.news-medical.net/news/20100504/Algal-DHA-improves-memory-function-in-healthy-aging-adults-MIDAS.aspx
- Alex A, Abbott KA, McEvoy M, Schofield PW, Garg ML. Long-chain omega-3 polyunsaturated fatty acids and cognitive decline in non-demented adults: a systematic review and meta-analysis. Nutrition Reviews. 2020;78(7):563–578. doi.org/10.1093/nutrit/nuz073
- Shahinfar H, Yazdian Z, Avini NA, Torabinasab K, Shab-Bidar S. A systematic review and dose response meta analysis of omega 3 supplementation on cognitive function. Scientific Reports. 2025;15(1):30610. doi.org/10.1038/s41598-025-16129-8
- Huang Y, Deng Y, Zhang P, et al. Associations of fish oil supplementation with incident dementia: evidence from the UK Biobank cohort study. Frontiers in Neuroscience. 2022;16:910977. doi.org/10.3389/fnins.2022.910977
- Yang L, Zhao F, Sun Y, et al. N-3 polyunsaturated fatty acids in elderly with mild cognitive impairment: a systemic review and meta-analysis. Journal of Alzheimer’s Disease. 2024;99(s1):S81–S95. doi.org/10.3233/JAD-220863
- Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. American Journal of Clinical Nutrition. 2015;102(1):215–221. doi.org/10.3945/ajcn.114.103283
- Oulhaj A, Jernerén F, Refsum H, Smith AD, de Jager CA. Omega-3 fatty acid status enhances the prevention of cognitive decline by B vitamins in mild cognitive impairment. Journal of Alzheimer’s Disease. 2016;50(2):547–557. doi.org/10.3233/JAD-150777
- Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Archives of Neurology. 2006;63(10):1402–1408. doi.org/10.1001/archneur.63.10.1402
- Alzforum. First trial of fish fats shows promise for early AD. 2006. alzforum.org/news/research-news/first-trial-fish-fats-shows-promise-early-ad
- Yassine HN, Pour SG, Juarez M, et al. CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial. eBioMedicine. 2026;129:106316. doi.org/10.1016/j.ebiom.2026.106316
- Cleveland Clinic. Atrial fibrillation (AFib). Updated 14 October 2026. my.clevelandclinic.org/health/diseases/16765-atrial-fibrillation-afib
- Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine ω-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981–1990. doi.org/10.1161/CIRCULATIONAHA.121.055654
- US Food and Drug Administration. Letter responding to the petition for a health claim for eicosapentaenoic acid and docosahexaenoic acid and reduction of blood pressure (Docket No. FDA-2014-Q-1146). June 2019. www.fda.gov/media/128043/download
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA Journal. 2012;10(7):2815. doi.org/10.2903/j.efsa.2012.2815
- Jackson PA, Deary ME, Reay JL, Scholey AB, Kennedy DO. No effect of 12 weeks’ supplementation with 1 g DHA-rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18–35 years. British Journal of Nutrition. 2012;107(8):1232–1243. doi.org/10.1017/S000711451100403X
- Stonehouse W, Conlon CA, Podd J, et al. DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. American Journal of Clinical Nutrition. 2013;97(5):1134–1143. doi.org/10.3945/ajcn.112.053371